Maintenance Treatment of Iron Deficiency in IBD Patients

Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.

NCT05581420 ·Status: UNKNOWN ·Phase: NA

Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy

NCT01428843 ·Status: TERMINATED ·Phase: PHASE3

A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease

NCT03466983 ·Status: COMPLETED ·Phase: PHASE4

Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

NCT01017614 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease

NCT01410435 ·Status: COMPLETED ·Phase: PHASE3

Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia

NCT01823029 ·Status: COMPLETED ·Phase: NA

Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate

NCT01991314 ·Status: COMPLETED ·Phase: PHASE4

Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue

NCT02517151 ·Status: UNKNOWN ·Phase: PHASE2

EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD

NCT06321887 ·Status: RECRUITING ·Phase: PHASE3

Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD

NCT02774057 ·Status: UNKNOWN ·Phase: PHASE4

Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )

NCT03247816 ·Status: COMPLETED

Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)

NCT01352221 ·Status: COMPLETED ·Phase: PHASE3

Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease

NCT05456932 ·Status: UNKNOWN ·Phase: PHASE4

Anemia in Inflammatory Bowel Disease

NCT02760940 ·Status: UNKNOWN ·Phase: PHASE4

Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease

NCT01599702 ·Status: COMPLETED ·Phase: PHASE3

Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial

NCT04587141 ·Status: UNKNOWN ·Phase: PHASE3

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

NCT03167437 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study

NCT00279435 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Research Study in Patients With Severe Ulcerative Colitis

NCT00032305 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis

NCT00152841 ·Status: TERMINATED ·Phase: PHASE2

Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

NCT01213680 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD

NCT05701501 ·Status: UNKNOWN ·Phase: NA

Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

NCT00307827 ·Status: TERMINATED ·Phase: PHASE2

Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization

NCT03182166 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

NCT03558152 ·Status: COMPLETED ·Phase: PHASE2